InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong
· Delayed Price · Currency is HKD 64.30
+2.10 (3.38%)
At close: Apr 29, 2026
HKG:3696 Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 393.34 | 125.94 | 177.18 | 207.88 |
| Trading Asset Securities | 53.93 | - | - | - |
| Cash & Short-Term Investments | 447.27 | 125.94 | 177.18 | 207.88 |
| Cash Growth | 255.14% | -28.92% | -14.77% | - |
| Accounts Receivable | 21.28 | 0.85 | 1.08 | 4.9 |
| Other Receivables | 3.64 | 3.84 | 3.83 | 1.43 |
| Receivables | 24.93 | 4.69 | 4.91 | 6.32 |
| Prepaid Expenses | 2.08 | 1.7 | 1.78 | 0.82 |
| Other Current Assets | - | 1.07 | 4.79 | 3.73 |
| Total Current Assets | 474.28 | 133.41 | 188.65 | 218.75 |
| Property, Plant & Equipment | 13.17 | 9.44 | 12.79 | 14.28 |
| Long-Term Investments | 0.72 | 0.25 | 0.41 | 1.03 |
| Other Intangible Assets | 0.27 | 0.27 | 0.38 | 0.19 |
| Other Long-Term Assets | 1.55 | 0.64 | 0.56 | 0.54 |
| Total Assets | 489.98 | 144 | 202.8 | 234.79 |
| Accounts Payable | 13.62 | 18.02 | 17.82 | 19.13 |
| Accrued Expenses | 11.92 | 12.79 | 11.64 | 7.02 |
| Current Portion of Leases | 1.9 | 1.5 | 1.27 | 1.38 |
| Current Income Taxes Payable | 0.29 | 0.23 | 0.23 | 0.29 |
| Current Unearned Revenue | 2.31 | 7.08 | 42.64 | 5.21 |
| Other Current Liabilities | 3.86 | 767.25 | 778.42 | 649.47 |
| Total Current Liabilities | 33.89 | 806.87 | 852.03 | 682.49 |
| Long-Term Leases | 4.06 | 1.06 | 0.93 | 1.84 |
| Total Liabilities | 37.96 | 807.93 | 852.95 | 684.33 |
| Additional Paid-In Capital | - | 0.62 | 0.21 | 0.21 |
| Retained Earnings | - | -680.56 | -663.46 | -451.82 |
| Treasury Stock | - | -2.05 | -11.35 | -11.35 |
| Comprehensive Income & Other | 452.03 | 18.06 | 24.44 | 13.42 |
| Shareholders' Equity | 452.03 | -663.92 | -650.16 | -449.54 |
| Total Liabilities & Equity | 489.98 | 144 | 202.8 | 234.79 |
| Total Debt | 5.96 | 2.56 | 2.19 | 3.22 |
| Net Cash (Debt) | 441.31 | 123.38 | 174.99 | 204.66 |
| Net Cash Growth | 257.68% | -29.49% | -14.50% | - |
| Net Cash Per Share | 5.61 | 1.72 | 2.59 | 3.05 |
| Filing Date Shares Outstanding | 557.42 | 77.24 | 67.57 | 67.06 |
| Total Common Shares Outstanding | 557.42 | 77.24 | 67.57 | 67.06 |
| Working Capital | 440.39 | -673.46 | -663.37 | -463.74 |
| Book Value Per Share | 0.81 | -8.60 | -9.62 | -6.70 |
| Tangible Book Value | 451.76 | -664.2 | -650.54 | -449.74 |
| Tangible Book Value Per Share | 0.81 | -8.60 | -9.63 | -6.71 |
| Machinery | - | 10.72 | 10.4 | 4.56 |
| Construction In Progress | - | 0.05 | 0.09 | 4.69 |
| Leasehold Improvements | - | 3.72 | 3.5 | 2.49 |
Source: S&P Capital IQ. Standard template. Financial Sources.